Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3101
-0.0127 (-3.93%)
At close: Jul 17, 2026, 4:00 PM EDT
0.3145
+0.0044 (1.42%)
After-hours: Jul 17, 2026, 7:56 PM EDT
Mereo BioPharma Group Revenue
Mereo BioPharma Group had revenue of $500.00K in the twelve months ending March 31, 2026. In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K.
Revenue (ttm)
$500.00K
Revenue Growth
n/a
P/S Ratio
99.00
Revenue / Employee
$12,821
Employees
39
Market Cap
49.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 500.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 49.37M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Radiopharm Theranostics | 10.86M |
| Immutep | 5.28M |
| BeyondSpring | 1.88M |
| Seres Therapeutics | 1.15M |
| aTyr Pharma | 190.00K |
| INmune Bio | 50.00K |
| Impact BioMedical | 39.00K |
| eXoZymes | -700.00 |
MREO News
- 2 months ago - 4basebio Announces Appointment of Chief Financial Officer and Board Changes - GlobeNewsWire
- 2 months ago - Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 3 months ago - Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky - GlobeNewsWire
- 3 months ago - MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO - GlobeNewsWire
- 3 months ago - MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO - Newsfile Corp
- 3 months ago - MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 3 months ago - MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Business Wire
- 3 months ago - Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO - PRNewsWire